previous compound ID: 1293 next compound
InChIKey: LOIYMIARKYCTBW-OWOJBTEDSA-N
SMILES: C1=C(NC=N1)/C=C/C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "JW Hanrahan" "B Kus" "J Liao" "DY Thomas" "SD Macknight" "D Rotin" "E Matthes" "J Goepp" "GW Carlile"

chemical graph of compound 1293





CID is 736715
synonyms found at PubChem are:
urocanic acid, 4-imidazoleacrylic acid, trans-Urocanic acid, 104-98-3, urocanate, Urocaninic acid, imidazoleacrylic acid, 5-Imidazoleacrylic acid, 3465-72-3, (2E)-3-(1H-IMIDAZOL-4-YL)ACRYLIC ACID, Imidazole-4-acrylic acid, 3-Imidazol-4-ylacrylic acid, 3-(1H-Imidazol-4-yl)-2-propenoic acid, UNII-G8D26XJJ3B, (E)-3-(1H-Imidazol-4-yl)-2-propenoic acid, (2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, NSC 66357, UROCANIC ACID, CIS, G8D26XJJ3B, (e)-3-(1h-imidazol-4-yl)acrylic acid, (E)-3-(1H-imidazol-5-yl)acrylic acid, 3-(4-Imidazolyl)acrylic acid, MLS000069482, CHEBI:30817, LOIYMIARKYCTBW-OWOJBTEDSA-N, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (2E)-, 3-(1H-imidazol-4-yl)prop-2-enoic acid, SMR000059098, Imidazole-4-propene-2-enoic acid [Urocanic acid], 4-IMIDAZOLE ACRYLIC ACID DIHYDRATE, CCRIS 3414, EINECS 203-258-4, (E)-Urocanic acid, BRN 0081405, (2E)-3-imidazol-4-ylprop-2-enoic acid, (E)-3-(imidazol-4-yl)propenoate, ProtoCure, 5-Imidazoleacrylate, zlchem 24, Imidazole-4-acrylate, imidazolylpropenoicacid, PubChem9875, (E)-3-(1H-Imidazol-5-yl)-2-propenoic acid, (Z)-3-(3H-imidazol-4-yl)prop-2-enoic Acid, AC1LEIQR, Opera_ID_26, 3-(4-Imidazolyl)acrylate, bmse000279, D04CQV, AC1Q5T9G, AC1Q71IX, DSSTox_CID_21148, DSSTox_RID_79635, DSSTox_GSID_41148, Lopac0_001255, SCHEMBL15417, trans-4-imidazoleacrylic acid, MLS001148240, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (E)-, 4-Imidazoleacrylic acid, 99%, AC1Q71Y1, Jsp000483, 3-(1H-Imidazol-4-yl)acrylate, CHEMBL1236602, DTXSID5041148, CHEBI:27248, ZLB0011, MolPort-001-763-955, MolPort-006-833-341, MolPort-009-660-446, E-3-(4-imidazolyl)propenoic acid, HMS2234N08, HMS3263L12, ACT02032, ALBB-025618, NSC66357, Tox21_202978, Tox21_501255, BBL027507, MFCD01593677, NSC-66357, NSC407934, SBB006702, STK735136, ZINC34633903, (E)-3-(imidazol-4-yl)acrylic acid, 3-(3H-Imidazol-4-yl)-acrylic acid, 3-(1H-Imidazol-4-yl)-2-propenoate, AKOS001745677, AKOS005265082, AKOS022488522, (e)-3-(Imidazol-4-yl)propenoic acid, CCG-205329, DB01971, HS-0075, LP01255, NSC-407934, RP09780, RTR-032578, NCGC00094495-01, NCGC00094495-02, NCGC00094495-03, NCGC00260524-01, NCGC00261940-01, CAS-104-98-3, CJ-18538, LS-78025, SC-00208, ST085933, 3-(1H-Imidazol-5-yl)-2-Propenoic acid, 3-Azonia-1H-imidazole-5-acrylic acidanion, HY-113008, KB-176840, KB-180998, TR-032578, (2E)-3-(1H-Imidazole-4-yl)propenoic acid, CS-0059340, EU-0101255, I0002, R1116, (E)-3-(1H-imidazol-4-yl)prop-2-enoic acid, (E)-3-(1H-imidazol-5-yl)prop-2-enoic acid, 3-(1H-Imidazol-4-yl)-(E)-2-Propenoic acid, C00785, U 7500, (2E)-3-(1H-imidazol-5-yl)prop-2-enoic acid, (2E)-3-(3H-imidazol-4-yl)prop-2-enoic acid, SR-01000076189, I04-0134, SR-01000076189-1, W-108797, ProtoCure (emulsion, atopic dermatitis), Biocis Pharma, 23A7DA77-EC02-46B9-AA22-514C2B2A62E9, ProtoCure (emulsion, atopic dermatitis/psoriasis), Laurantis, Anti-inflammatory (topical emulsion, dermatological disease), BioCis, Cis-UCA (topical emulsion, atopic dermatitis/psoriasis), Laurantis, ProtoCure (emulsion, atopic dermatitis/psoriasis), Biocis Pharma, Cis-UCA (topical emulsion, atopic dermatitis/psoriasis), BioCis Pharma, Cis-urocanic acid (topical emulsion, atopic dermatitis/psoriasis), BioCis Pharma, 7699-36-7